CHECKMATE-649 also showed that in advanced GC (AGC) and EGJ cancers, nivolumab combined with chemotherapy resulted in better OS than chemotherapy alone, especially when PD-L1 is combined with CPS ≥ 5 [64]. Here, CD274 is linked to gastric cancer.